Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $143.5200 (0.03%) ($142.8900 - $144.3800) on Tue. Oct. 24, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.12% (three month average) | RSI | 75 | Latest Price | $143.5200(0.03%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.2% a day on average for past five trading days. | Weekly Trend | LGND advances 0.9% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(57%) XBI(56%) IWC(53%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -0.56% in a week (0% probabilities). TLT(-15%) VIXM(-14%) UUP(-8%) GDXJ(-6%) IGOV(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.56% (StdDev 1.12%) | Hourly BBV | 0 () | Intraday Trend | -0% | | | |
|
5 Day Moving Average | $143.69(-0.12%) | 10 Day Moving Average | $143.21(0.22%) | 20 Day Moving Average | $141(1.79%) | To recent high | -0.4% | To recent low | 18.7% | Market Cap | $2.307b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |